Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype (Q33922150)

30 July 2017

title

Age and survival estimates in patients who have node-negative T1ab breast cancer by breast cancer subtype (English)

1 reference

30 July 2017

1 reference

Mariana Chavez-MacGregor

Mariana Chavez-Macgregor

6

0 references

Wendy A Woodward

Wendy A Woodward

8

0 references

Funda Meric-Bernstam

5

Funda Meric-Bernstam

1 reference

Ana Maria Gonzalez-Angulo

30 July 2017

11

Ana M Gonzalez-Angulo

1 reference

30 July 2017

10

Gabriel N Hortobagyi

1 reference

30 July 2017

Rachel L Theriault

1

1 reference

30 July 2017

Jennifer K Litton

2

1 reference

30 July 2017

Elizabeth A Mittendorf

3

1 reference

30 July 2017

Huiqin Chen

4

1 reference

30 July 2017

Phuong K Morrow

7

1 reference

30 July 2017

Aysegul Sahin

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

20 July 2011

1 reference

30 July 2017

published in

Clinical Breast Cancer

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

325-331

1 reference

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Prognosis and Outcome of Small (≤1 cm), Node-Negative Breast Cancer on the Basis of Hormonal and HER-2 Status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Women age < or = 35 years with primary breast carcinoma: disease features at presentation

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Sentinel lymph node biopsy in patients with multifocal breast cancer.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4104010

Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer

29 October 2018

1 reference

12 December 2020

Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of f

1 reference

12 December 2020

Nuclear structure in cancer tissues

1 reference

12 December 2020

Breast conservation after neoadjuvant chemotherapy

1 reference

12 December 2020

10.1016/J.CLBC.2011.05.002

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/464kwmzwa5hhdngwu3ro2uzbte

30 July 2022

release_464kwmzwa5hhdngwu3ro2uzbte

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/464kwmzwa5hhdngwu3ro2uzbte

30 July 2022

https://api.fatcat.wiki/v0/release/464kwmzwa5hhdngwu3ro2uzbte

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/464kwmzwa5hhdngwu3ro2uzbte

1 reference

30 July 2022